Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...

Inspire Medical Systems, Inc. ( NYSE: INSP) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive ...

CEO Tim Herbert highlighted milestones in 2024, including surpassing 90,000 patients treated with Inspire therapy, FDA approval of the Inspire V neurostimulator, and achieving full-body MRI ...

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inspire Medical Systems (INSP – Research ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zoetis (ZTS – Research Report), Inspire Medical Systems ...

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally ...

Inspire Medical ( ($INSP) ) has released its Q4 earnings. Here is a breakdown of the information Inspire Medical presented to its investors.

The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.

During its fourth-quarter earnings call this week, Inspire Medical disclosed that it has become the subject of a civil probe ...

The Trump administration is moving rapidly to gut the Consumer Financial Protection Bureau (CFPB), halting the agency’s work, ...